WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 374

Legislative bill overview

HB 374 establishes requirements for prescription drug labeling to be compatible with electronic readers and devices designed for visually impaired patients. The bill appears to mandate that pharmacies and pharmaceutical manufacturers ensure prescription labels can be scanned or read by assistive technology, making medication information accessible without requiring sighted assistance.

Why is this important

Approximately 2 million Americans are legally blind or visually impaired, and accessing medication information independently is a critical health and safety issue. Current prescription labels are often inaccessible to visually impaired patients, forcing them to rely on others for medication verification, dosage confirmation, and potential drug interaction warnings—creating barriers to autonomy and medication safety.

Potential points of contention

  • Implementation costs: Manufacturers and pharmacies may argue that redesigning labeling systems and sourcing compatible technology creates significant financial burden, particularly for smaller operations
  • Technology standards: Lack of consensus on which reading devices/formats should be supported could create compliance complexity and fragmentation across the state
  • Enforcement mechanism: The bill's specificity on penalties, timelines for compliance, and oversight authority remain unclear without seeing full legislative text

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.